United Therapeutics (UTHR) Current Assets (2009 - 2026)

United Therapeutics (UTHR) has 18 years of Current Assets data on file, last reported at $2.9 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 27.1% year-over-year to $2.9 billion; the trailing twelve-month figure through Mar 2026 stood at $2.9 billion (down 27.1% YoY), and the FY2025 full-year result was $3.7 billion, down 4.42% from the prior year.
• Current Assets retreated to $2.9 billion in Q1 2026, from $3.7 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $4.0 billion in Q3 2024 to a low of $2.6 billion in Q1 2022.
• A 5-year average of $3.4 billion and a median of $3.5 billion in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets jumped 45.48% in 2022 and declined 27.1% in 2026, its largest moves.
• Tracing UTHR's Current Assets over 5 years: stood at $3.4 billion in 2022, then advanced by 5.05% to $3.6 billion in 2023, then rose by 9.09% to $3.9 billion in 2024, then dropped by 4.42% to $3.7 billion in 2025, then slipped by 22.43% to $2.9 billion in 2026.
• Business Quant data shows UTHR's Current Assets at $2.9 billion in Q1 2026, $3.7 billion in Q4 2025, and $3.5 billion in Q3 2025.